TYSABRI
EUROPEAN COMMISSION APPROVES INCLUSION OF ANTI-JC VIRUS ANTIBODY STATUS AS A PML RISK FACTOR IN TYSABRI LABELING
CONFIRM
NEW PUBLICATION OF REAL-WORLD TYSABRI? DATA SHOW SIGNIFICANT REDUCTIONS IN KEY CLINICAL MEASURES OF DISEASE ACTIVITY WITH LONGER-TERM USE
NEW TYSABRI? DATA SHOW EARLIER TREATMENT AND LONGER-TERM USE RESULT IN SIGNIFICANT REDUCTIONS IN MS DISEASE ACTIVITY
BIOGEN IDEC COMPLETES PURCHASE OF FULL RIGHTS AND CONTROL OF TYSABRI?
- LIDDS listas p? Nasdaq OMX First North
- Region Sk?ne tar spjutspetsfr?gorna till Danmark
- Gj?r deg klar for solen med betakaroten!
- Jak dostać się do izolatorium – Przechodzisz łagodnie zakażenie koronawirusem i chcesz chronić swoich najbliższych przed infekcją
- Mindfulness: Slik forlenger du sinnsroen etter ferien